Magnetic resonance enterography to predict subsequent disabling Crohn’s disease in newly diagnosed patients (METRIC-EF)—multivariable prediction model, multicentre diagnostic inception cohort - Quiz - MDSpire

Magnetic resonance enterography to predict subsequent disabling Crohn’s disease in newly diagnosed patients (METRIC-EF)—multivariable prediction model, multicentre diagnostic inception cohort

  • By

  • Stuart A. Taylor

  • Shankar Kumar

  • Thomas Parry

  • Sue Mallett

  • Simon Travis

  • Tim Raine

  • Caroline Clarke

  • Jing Yi Weng

  • Gauraang Bhatnagar

  • Stuart Bloom

  • Peter John Hamlin

  • Ailsa Hart

  • Roser Vega

  • Maira Hameed

  • Anisha Bhagwanani

  • Rebecca Greenhalgh

  • Emma Helbren

  • James Stephenson

  • Ian Zealley

  • Vivienne Eze

  • Jamie Franklin

  • Alison Corr

  • Arun Gupta

  • Damian Tolan

  • William Hogg

  • Antony Higginson

  • Mohamed Ahmed

  • Louise Lee

  • Richard Pollok

  • Jaymin Patel

  • Samantha Baillie

  • Steve Halligan

  • Andrew Plumb

  • May 14, 2025

  • 0 min

Share

Original Source(s)

Magnetic resonance enterography to predict subsequent disabling Crohn’s disease in newly diagnosed patients (METRIC-EF)—multivariable prediction model, multicentre diagnostic inception cohort

  • by Stuart A. Taylor, Shankar Kumar, Thomas Parry, Sue Mallett, Simon Travis, Tim Raine, Caroline Clarke, Jing Yi Weng, Gauraang Bhatnagar, Stuart Bloom, Peter John Hamlin, Ailsa Hart, Roser Vega, Maira Hameed, Anisha Bhagwanani, Rebecca Greenhalgh, Emma Helbren, James Stephenson, Ian Zealley, Vivienne Eze, Jamie Franklin, Alison Corr, Arun Gupta, Damian Tolan, William Hogg, Antony Higginson, Mohamed Ahmed, Louise Lee, Richard Pollok, Jaymin Patel, Samantha Baillie, Steve Halligan, Andrew Plumb

  • May 14, 2025

Related Content

Mammography AI Spots Vascular Signals

Routine breast imaging offers opportunity for cardiovascular risk assessment.

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Tenecteplase Fails to Boost EVT Outcomes

Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.